DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) today announced the public offering of 2,419,932 shares of its common stock. Morgan Stanley & Co. Incorporated will be the sole underwriter for the offering.
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) today announced the public offering of 2,419,932 shares of its common stock. Morgan Stanley & Co. Incorporated will be the sole underwriter for the offering.
